- Home
- LEXX vs PRTS Comparison
LEXX vs PRTS Comparison
Compare LEXX & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- PRTS
- Stock Information
- Founded
- LEXX 2004
- PRTS 1995
- Country
- LEXX Canada
- PRTS United States
- Employees
- LEXX N/A
- PRTS N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- PRTS Auto & Home Supply Stores
- Sector
- LEXX Health Care
- PRTS Consumer Discretionary
- Exchange
- LEXX Nasdaq
- PRTS Nasdaq
- Market Cap
- LEXX 49.3M
- PRTS 48.4M
- IPO Year
- LEXX N/A
- PRTS 2007
- Fundamental
- Price
- LEXX $2.88
- PRTS $0.80
- Analyst Decision
- LEXX Strong Buy
- PRTS Buy
- Analyst Count
- LEXX 2
- PRTS 4
- Target Price
- LEXX $11.00
- PRTS $2.33
- AVG Volume (30 Days)
- LEXX 91.4K
- PRTS 318.6K
- Earning Date
- LEXX 11-18-2024
- PRTS 10-29-2024
- Dividend Yield
- LEXX N/A
- PRTS N/A
- EPS Growth
- LEXX N/A
- PRTS N/A
- EPS
- LEXX N/A
- PRTS N/A
- Revenue
- LEXX $411,019.00
- PRTS $633,818,000.00
- Revenue This Year
- LEXX $82.02
- PRTS N/A
- Revenue Next Year
- LEXX $95.09
- PRTS $2.32
- P/E Ratio
- LEXX N/A
- PRTS N/A
- Revenue Growth
- LEXX 34.05
- PRTS N/A
- 52 Week Low
- LEXX $0.94
- PRTS $0.72
- 52 Week High
- LEXX $6.85
- PRTS $4.01
- Technical
- Relative Strength Index (RSI)
- LEXX 44.61
- PRTS 37.52
- Support Level
- LEXX $2.97
- PRTS $0.87
- Resistance Level
- LEXX $3.39
- PRTS $0.95
- Average True Range (ATR)
- LEXX 0.19
- PRTS 0.04
- MACD
- LEXX -0.01
- PRTS -0.01
- Stochastic Oscillator
- LEXX 26.97
- PRTS 7.14
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.